EQUITIES

Robust. Fundamental. Dynamic.

Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

vd-icon_Currency_CashUSD

$229.4bn
Equities Assets Under Management

vd-icon_People_3_Group v3

152
Equities Investment
Professionals

vd-icon_Bulleye_Target v3

20
Average Years’ Financial
Industry Experience

As at December 31, 2024

<span class="notranslate">no data</span>

$229.4bn
Equities Assets Under Management

152
Equities Investment
Professionals

20
Average Years’ Financial
Industry Experience

As at December 31, 2024

We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.

Featured strategies

Global Life Sciences

By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies.

Global Technology Leaders

A global approach to investing in technology companies from a highly experienced team

Insights

Quick View: How are tariffs reshaping the market for European smaller caps?

As the impact of a new tariff regime spreads across the market, Portfolio Manager Ollie Beckett considers the potential for European smaller companies to adapt and thrive.

Tech stocks and tariffs: 5 key considerations for investors

A discussion on how tariffs will impact the technology sector.

Identifying opportunities amid dislocation

Assessing the market reaction to President Trump’s tariffs and where we’re seeing opportunities as a result of the dislocation.